Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P63000: Variant p.Asp63Gly

Ras-related C3 botulinum toxin substrate 1
Gene: RAC1
Feedback?
Variant information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Glycine (G) at position 63 (D63G, p.Asp63Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 192 The length of the canonical sequence.
Location on the sequence: help NVMVDGKPVNLGLWDTAGQE D YDRLRPLSYPQTDVFLICFS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 189 Ras-related C3 botulinum toxin substrate 1
Binding site 60 – 60
Modified residue 71 – 71 Phosphoserine
Alternative sequence 75 – 75 T -> TVGETYGKDITSRGKDKPIA. In isoform B.
Mutagenesis 56 – 56 W -> A. Strongly reduced interaction with PLCB2.
Mutagenesis 61 – 61 Q -> L. Constitutively active. Interacts with PARD6 proteins. Interacts with PPP5C, activates its phosphatase activity and translocates PPP5C to the plasma membrane. No effect on interaction with RAPH1. Interacts with CYRIB. No interaction with PPP5C; when associated with V-30 or S-35. Translocates to the plasma membrane; also when associated with V-30 or S-35.
Mutagenesis 67 – 67 L -> A. Strongly reduced interaction with PLCB2.
Mutagenesis 70 – 70 L -> A. Strongly reduced interaction with PLCB2.
Mutagenesis 71 – 71 S -> A. Loss of AKT-mediated phosphorylation and FBXL19-induced polyubiquitination.
Helix 62 – 64



Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.